Literature DB >> 7507550

Burkholderia pseudomallei and melioidosis: be aware in temperate area.

E Yabuuchi1, M Arakawa.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 7507550     DOI： 10.1111/j.1348-0421.1993.tb01712.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


× No keyword cloud information.
  15 in total

1.  Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

Authors:  K Miyagi; K Kawakami; A Saito
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Variability of Burkholderia pseudomallei strain sensitivities to chlorine disinfection.

Authors:  Heather A O'Connell; Laura J Rose; Alicia Shams; Meranda Bradley; Matthew J Arduino; Eugene W Rice
Journal:  Appl Environ Microbiol       Date:  2009-06-19       Impact factor: 4.792

3.  Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin.

Authors:  P Utaisincharoen; N Tangthawornchaikul; W Kespichayawattana; N Anuntagool; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

5.  Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages.

Authors:  P Utaisincharoen; N Anuntagool; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.

Authors:  Ediane B Silva; Andrew Goodyear; Marjorie D Sutherland; Nicole L Podnecky; Mercedes Gonzalez-Juarrero; Herbert P Schweizer; Steven W Dow
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

7.  In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.

Authors:  R Perumal Samy; A Pachiappan; P Gopalakrishnakone; Maung M Thwin; Yap E Hian; Vincent T K Chow; Ho Bow; Joseph T Weng
Journal:  BMC Infect Dis       Date:  2006-06-20       Impact factor: 3.090

8.  Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis.

Authors:  Yiting Yu; H Stanley Kim; Hui Hoon Chua; Chi Ho Lin; Siew Hoon Sim; Daoxun Lin; Alan Derr; Reinhard Engels; David DeShazer; Bruce Birren; William C Nierman; Patrick Tan
Journal:  BMC Microbiol       Date:  2006-05-26       Impact factor: 3.605

9.  Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand.

Authors:  Lily A Trunck; Katie L Propst; Vanaporn Wuthiekanun; Apichai Tuanyok; Stephen M Beckstrom-Sternberg; James S Beckstrom-Sternberg; Sharon J Peacock; Paul Keim; Steven W Dow; Herbert P Schweizer
Journal:  PLoS Negl Trop Dis       Date:  2009-09-22

10.  Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates.

Authors:  N Anuntagool; P Intachote; V Wuthiekanun; N J White; S Sirisinha
Journal:  Clin Diagn Lab Immunol       Date:  1998-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.